Abstract:

The evaluation of saponin-rich fractions for anticancer activity can lead to the discovery of new chemical entities or derivatives with improved efficacy and reduced side effects. Nature often presents a diverse range of structurally distinct compounds, and saponins are no exception. By analyzing different plant sources, it becomes possible to identify novel saponins or modify existing ones to enhance their anticancer potential. This can contribute to the development of safer and more effective treatments for cancer patients. The evaluation of saponin-rich fractions can also provide valuable insights into the underlying mechanisms of action. Understanding how these compounds interact with cancer cells and the molecular pathways they modulate can uncover new targets for drug development. This knowledge can help in the design of more specific and selective therapies, minimizing off-target effects and improving overall treatment outcomes. The evaluation of saponin-rich fractions from selected plants contributes to the conservation and sustainable use of plant resources. By identifying specific plants that contain valuable anticancer compounds, efforts can be made to cultivate and harvest them responsibly. This approach ensures the long-term availability of these plant sources for therapeutic purposes while minimizing the impact on the environment

Description:

Risk Factors, Breast Cancer, Initiation and Progression